[1. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation myocardial infarction in Europe: description of the situation in 30 countries. Eur Heart J. 2010;31:943-957. doi: 10.1093/eurheartj/ehp492.10.1093/eurheartj/ehp492]Search in Google Scholar
[2. Schröder R. Prognostic Impact of Early ST segment Resolution in Acute Myocardial Infarction. Circulation. 2004;110:e506-e510. doi: 10.1161/01.CIR.0000147778.05979.E6.10.1161/01.CIR.0000147778.05979.E6]Search in Google Scholar
[3. McLaughlin MG, Stone GW, Amyong E, et al. Prognostic utility of comparative methods for assessment of ST segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004;44:1215-1223. doi: 10.1016/j.jacc.2004.06.053.10.1016/j.jacc.2004.06.053]Search in Google Scholar
[4. de Lemos JA, Braunwald E. ST segment Resolution as a Tool for Assessing the Efficacy of Reperfusion Therapy. J Am Coll Cardiol. 2001;38:1283-1294.10.1016/S0735-1097(01)01550-9]Search in Google Scholar
[5. Schröder R, Weigscheider R, Schröder K, et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol. 1995;26:1657-1664.10.1016/0735-1097(95)00372-X]Search in Google Scholar
[6. Mauri F, Maggioni AP, Franzosi MG, et al. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza ell’Infarto Miocardico (GISSI-2) – Derived Analysis. J Am Coll Cardiol. 1994;24:600-607.10.1016/0735-1097(94)90003-5]Search in Google Scholar
[7. McLaughlin MG, Stone GW, Amyong E, et al. Prognostic Utility of Comparative Methods for Assessment of ST segment Resolution After Primary Angioplasty for Acute Myocardial Infarction – The CADILLAC trial. J Am Coll Cardiol. 2004 Sep 15;44:1215-1223. doi: 10.1016/j.jacc.2004.06.053.10.1016/j.jacc.2004.06.053]Search in Google Scholar
[8. Bename H, Taffet M, Bataille S, et al. Female gender still an independent predictor of in-hospital mortality after STEMI in the era of primary PCI? Insights from the Greater Paris Area PCI Registry. EuroIntervention. 2011;6(9):1073-9. doi: 10.4244/EIJV6I9A187.10.4244/EIJV6I9A187]Search in Google Scholar
[9. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: A systematic overview. Lancet. 2000;355(9206):773-778. doi: 10.1016/S0140-6736(99)08415-9.10.1016/S0140-6736(99)08415-9]Search in Google Scholar
[10. Hsu PH, Jou YL, Lin PL, et al. Comparison of In-hospital outcome of Acute ST. Acta Cardiol Sin. 2011;27:145-151.]Search in Google Scholar
[11. Kosuge M, Kimura K, Kojima S, et al. Impact of body mass index on in hospital outcome after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008;72:521-525.10.1253/circj.72.52118362419]Search in Google Scholar
[12. Wienbergen H. Gih AK, Juenger C, et al. Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clinical Research in Cardiology. 2008;97:83-88. doi: 10.1007/s00392-007-0585-x.10.1007/s00392-007-0585-x17938850]Search in Google Scholar
[13. Payvar SP, Kim S, Rao E, et al. In hospital outcomes of percutaneous coronary interventions in extremely obese and normal weight patients. J Am Coll Cardiol. 2013;62:692-696. doi: 10.1016/j.jacc.2013.05.058.10.1016/j.jacc.2013.05.05823948513]Search in Google Scholar
[14. Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST segment elevation myorcardial infarction, results from the NCDR (National Cardiovascular Registry). J Am Coll Cardiol. 2011;58:2642-50. doi: 10.1016/j.jacc.2011.09.030.10.1016/j.jacc.2011.09.030352332322152950]Search in Google Scholar
[15. Wang W, Chen QF, Yin RX, et al. Clinical features, risk factors, and treatment experience: a review of 74 patients with ST segment elevation myocardial infarction complicated by ventricular fibrillation. J Emerg Med. 2014;47:729-735. doi: 10.1016/j.jemermed.2014.06.041.10.1016/j.jemermed.2014.06.04125278138]Search in Google Scholar
[16. Kang DG, Jeong MH, Ahn Y, et al. Clinical effects of hypertension on mortality of patients with acute myocardial infarction. J Korean Med Sci. 2009;24:800-806. doi: 10.3346/jkms.2009.24.5.800.10.3346/jkms.2009.24.5.800275275919794974]Search in Google Scholar
[17. Abtahian F, Olenchock B, Ou FS, et al. Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry). Am J Cardiol. 2011;107:1441-6. doi: 10.1016/j.amjcard.2011.01.020.10.1016/j.amjcard.2011.01.020374341621420059]Search in Google Scholar
[18. Przylusk J, Kalinczuk L, Kruk M, et al. Early risk stratification in patients treated with primary PCI for STEMI based on simultaneous assessment of admission WBC count and levels of glycemia and creatinine. Circulation. 2006;114(Suppl18)]Search in Google Scholar
[19. Lipšic E, van der Horst ICC, Voors AA, et al. Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol. 2005;100:289-292.10.1016/j.ijcard.2004.10.04315823637]Search in Google Scholar
[20. Shiraishi J, Kohno Y, Sawada T, et al. Prognostic impact of systolic blood pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction. J Cardiol. 2012;60:139-144. doi: 10.1016/j.jjcc.2012.02.008.10.1016/j.jjcc.2012.02.00822521431]Search in Google Scholar